» Articles » PMID: 3800708

Hepatic Ultrastructural Changes and Liver Dysfunction in Amyotrophic Lateral Sclerosis

Overview
Journal Arch Neurol
Specialty Neurology
Date 1987 Jan 1
PMID 3800708
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Ultrastructural changes of hepatocytes were studied in liver biopsy specimens obtained from 21 patients with amyotrophic lateral sclerosis (ALS). In all specimens, one or more of the following abnormal findings were made: bizarre giant mitochondria; intramitochondrial paracrystalline inclusions; disorganization of the lamellar structure of rough endoplasmic reticulum; increased numbers of smooth endoplasmic reticulum; and/or parasinusoidal fibrosis. Above all, paracrystalline inclusions appeared to be a highly specific finding in ALS. In light of the above pathologic findings, we evaluated the liver function tests of 37 patients (including the above-mentioned 21 patients) with ALS, and found a high incidence of mild liver dysfunction. In spite of its subtleness, these ultrastructural changes of hepatocytes were consistently found in such patients, and offer further insight into the intrahepatic metabolic abnormalities in ALS.

Citing Articles

Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations.

Jin Y, Conneely K, Ma W, Naviaux R, Siddique T, Allen E Cell Biosci. 2025; 15(1):26.

PMID: 39980027 PMC: 11843967. DOI: 10.1186/s13578-025-01366-1.


Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment.

Cuffaro F, Lamminpaa I, Niccolai E, Amedei A Nutrients. 2025; 17(1.

PMID: 39796536 PMC: 11722677. DOI: 10.3390/nu17010102.


Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.

Cunha-Oliveira T, Montezinho L, Simoes R, Carvalho M, Ferreiro E, Silva F Cells. 2024; 13(3.

PMID: 38334639 PMC: 10854804. DOI: 10.3390/cells13030248.


The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis.

Gentile F, Maranzano A, Verde F, Bettoni V, Colombo E, Doretti A J Neurol. 2023; 271(2):794-803.

PMID: 37801095 PMC: 10827966. DOI: 10.1007/s00415-023-12015-3.


Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.

Maksimovic K, Youssef M, You J, Sung H, Park J Biomolecules. 2023; 13(5).

PMID: 37238732 PMC: 10216611. DOI: 10.3390/biom13050863.